Detalles de la búsqueda
1.
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.
Invest New Drugs
; 40(3): 622-633, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35312941
2.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(22): 2078-2092, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658856
3.
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
N Engl J Med
; 375(2): 134-42, 2016 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27410922
4.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27745820
5.
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited Tissue.
Oncology (Williston Park)
; 32(10): 499-500, 504, 2018 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30334239
6.
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.
J Clin Oncol
; 41(11): 1992-1998, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809080
7.
Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 14(10)2022 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626103
8.
The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.
Cancers (Basel)
; 13(20)2021 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680354
9.
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407.
J Thorac Oncol
; 16(11): 1883-1892, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34265431
10.
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC.
J Thorac Oncol
; 16(1): 162-168, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33069888
11.
Treatment of melanoma-associated retinopathy.
Curr Treat Options Neurol
; 12(1): 54-63, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20842490
12.
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program.
Surg Open Sci
; 2(4): 25-31, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32954245
13.
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study.
J Clin Oncol
; 38(21): 2427-2437, 2020 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479189
14.
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
J Clin Oncol
; 38(14): 1505-1517, 2020 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150489
15.
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
J Immunother Cancer
; 7(1): 342, 2019 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801624
16.
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.
Lung Cancer
; 130: 59-66, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30885353
17.
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Thorac Oncol
; 14(1): 124-129, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30138764
18.
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
JCO Precis Oncol
; 2: 1-12, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135120
19.
Favorable Response to Pembrolizumab in a Patient With Metastatic Castration-Resistant Prostate Cancer Progressing While Receiving Enzalutamide.
Clin Genitourin Cancer
; 17(2): e365-e368, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30587403
20.
Phase II study of topotecan and bevacizumab in advanced, refractory non--small-cell lung cancer.
Clin Lung Cancer
; 14(5): 495-501, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23816875